ALPHA TAU MEDICAL LTD-CL A Share Price Today: Live Updates & Key Insights

ALPHA TAU MEDICAL LTD-CL A share price today is $12.35, up -5.59%. The stock opened at $13.27 against the previous close of $13.24, with an intraday high of $13.27 and low of $12.415.

ALPHA TAU MEDICAL LTD-CL A Share Price Chart

ALPHA TAU MEDICAL LTD-CL A

us-stock
To Invest in {{usstockname}}
us-stock

ALPHA TAU MEDICAL LTD-CL A Share Price Performance

$12.35 -0.0559(-5.59%) DRTS at 27 Jul 2026 02:44 PM Biotechnology
Lowest Today 12.415
Highest Today 13.27
Today’s Open 13.27
Prev. Close 13.24
52 Week High 14.11
52 Week Low 2.87
Day’s Range: Low 12.415 High 13.27
52-Week Range: Low 2.87 High 14.11
1 day return -
1 Week return -7.27
1 month return +14.48
3 month return +57.9
6 month return +70.16
1 year return +321.95
3 year return +224.41
5 year return +27.31
10 year return -

ALPHA TAU MEDICAL LTD-CL A Institutional Holdings

HighTower Advisors, LLC 0.97

Aquamarine Financial (Cayman) Ltd 0.80

Pier Capital Small Cap Growth Equity 0.46

Apella Capital, LLC 0.42

ARK Investment Management LLC 0.32

UBS Group AG 0.32

ARK Israel Innovative Technology ETF 0.31

SEB Nordamerikafond Småbolag 0.28

SEB Credit Opportunity V UC SEK 25 MSEK 0.17

Kovitz Investment Group Partners, LLC 0.16

Mariner Wealth Advisors LLC 0.16

Daytona Street Capital LLC 0.16

Gem Investment Advisors, LLC 0.13

Easterly Investment Partners. 0.12

Adara Smaller Companies 0.09

Jane Street Group LLC 0.08

Fidelity Nasdaq Composite Index 0.06

Geode Capital Management, LLC 0.06

Dunham Small Cap Growth N 0.06

Wells Fargo & Co 0.05

Private Advisor Group, LLC 0.05

Millennium Management LLC 0.05

Bank of America Corp 0.05

Satovsky Asset Management LLC 0.05

Renaissance Technologies Corp 0.04

Citadel Advisors Llc 0.04

Northern Trust Corp 0.04

Even Herd Long Short ETF 0.03

Merlin MSMID50 0.02

BlackRock Global Equity Mkt Netrl Instl 0.02

Avantis Responsible International Eq ETF 0.01

Polen 5Perspectives Ultra-Small Growth C 0.01

Principal Small Cap Growth 0.00

Avantis CIBC International Equity ETF 0.00

ALPHA TAU MEDICAL LTD-CL A Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

ALPHA TAU MEDICAL LTD-CL A Fundamentals

Market Cap 1195.91 M

PB Ratio 17.3092

PE Ratio 0.0

Enterprise Value 1138.35 M

Total Assets 106.58 M

Volume 364658

ALPHA TAU MEDICAL LTD-CL A Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-25188000 -25.2M, FY22:-33762000 -33.8M, FY21:-27271000 -27.3M, FY20:-8882000 -8.9M, FY19:-8464000 -8.5M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-22939000 -22.9M, Q3/2025:-11686000 -11.7M, Q2/2025:-10114000 -10.1M, Q1/2025:-8691000 -8.7M, Q3/2024:-6924000 -6.9M

About ALPHA TAU MEDICAL LTD-CL A & investment objective

Company Information Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Organisation Biotechnology

Employees 121

Industry Biotechnology

CEO Mr. Uzi Sofer

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ALPHA TAU MEDICAL LTD-CL A FAQs

What is the share price of ALPHA TAU MEDICAL LTD-CL A today?

The current share price of ALPHA TAU MEDICAL LTD-CL A is $12.35.

Can I buy ALPHA TAU MEDICAL LTD-CL A shares in India?

Yes, Indian investors can buy ALPHA TAU MEDICAL LTD-CL A shares by opening an international trading and demat account with Motilal Oswal.

How to buy ALPHA TAU MEDICAL LTD-CL A shares in India?

You can easily invest in ALPHA TAU MEDICAL LTD-CL A shares from India by:

Can I buy fractional shares of ALPHA TAU MEDICAL LTD-CL A?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ALPHA TAU MEDICAL LTD-CL A?

ALPHA TAU MEDICAL LTD-CL A has a market cap of $1195.91 M.

In which sector does ALPHA TAU MEDICAL LTD-CL A belong?

ALPHA TAU MEDICAL LTD-CL A operates in the Biotechnology sector.

What documents are required to invest in ALPHA TAU MEDICAL LTD-CL A stocks?

To invest, you typically need:

What is the PE and PB ratio of ALPHA TAU MEDICAL LTD-CL A?

The PE ratio of ALPHA TAU MEDICAL LTD-CL A is N/A and the PB ratio is 17.31.